Suzanne Egyhazi Brage
6PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 12, 2021
Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.Max J Karlsson, Fernanda Costa Svedman, Abdellah Tebani
|Oct 21, 2020
Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma.Ishani Das, Huiqin Chen, Gianluca Maddalo
|Jan 11, 2020
AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma.Ishani Das, Helge Gad, Lars Bräutigam
|Sep 12, 2019
Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status.Ishani Das, Margareta Wilhelm, Veronica Höiom
|Oct 20, 2017
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.Alireza Azimi, Rainer Tuominen, Fernanda Costa Svedman
Pageof 1
Frequent Collaborators
3 joint publications
Ishani Das
2 joint publications
Gianluca Maddalo
1 joint publications
Rodolfo Franco Marquez
1 joint publications
Ulrika Warpman Berglund
1 joint publications
Meenhard Herlyn
1 joint publications
Michael A Davies
1 joint publications
Max J Karlsson
1 joint publications
Fernanda Costa Svedman
1 joint publications
Abdellah Tebani
1 joint publications
David Kotol
